Real-time SEC alerts Start Free →
Profitelligence
Edwards Lifesciences Corporation
EW HIGH Impact

Edwards Lifesciences Corporation

Edwards Lifesciences Announces Retirement of Principal Accounting Officer

| 8-K |Healthcare

Summary

Edwards Lifesciences Corporation announced that Robert W.A. Sellers, Senior Vice President, Principal Accounting Officer, will retire effective July 1, 2024. He will be succeeded by Andrew M. Dahl, currently Senior Vice President and Corporate Controller of the Company. Dahl, aged 47, joined Edwards in February 2024 after serving in various capacities at Medtronic PLC and as Director of Internal Audit at Polaris Industries.

Profitelligence Profitelligence Alerts

Get alerts for EW

Be first to know when Edwards Lifesciences Corporation files with the SEC.

Set Up Alerts →

Filing Categories

Key Executive Departure New CAO Appointed

Advertisement

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a leading healthcare company primarily known for its innovative medical devices focused on cardiovascular conditions. The firm's primary function revolves around the development and commercialization of heart valve products and hemodynamic monitoring systems, aimed at enhancing the life quality of patients suffering from cardiovascular diseases. Edwards Lifesciences plays a crucial role in the healthcare sector, particularly impacting the cardiology and surgical fields. Notable for its pioneering work in heart valve therapies, the corporation is at the forefront of transcatheter aortic valve replacement (TAVR) technology, a minimally invasive procedure that offers a significant alternative to traditional open-heart surgeries. Edwards Lifesciences collaborates closely with healthcare professionals to ensure its products address critical medical needs globally. Headquartered in Irvine, California, Edwards Lifesciences operates in a highly competitive and rapidly advancing market, where technological innovation and patient outcomes are pivotal. Its contributions continue to set standards within the medical device industry, reinforcing its market significance by addressing demands for effective cardiovascular care solutions worldwide.

Exchange: NYSE Industry: Medical Devices Company Website →

Official SEC Documents

EW
EW Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement